nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—SCN5A—dilated cardiomyopathy	0.744	1	CbGaD
Orphenadrine—SCN5A—purkinje fiber—dilated cardiomyopathy	0.0335	0.297	CbGeAlD
Orphenadrine—KCNH2—purkinje fiber—dilated cardiomyopathy	0.0206	0.182	CbGeAlD
Orphenadrine—SCN5A—endocardium—dilated cardiomyopathy	0.0173	0.153	CbGeAlD
Orphenadrine—SCN5A—sinoatrial node—dilated cardiomyopathy	0.0164	0.145	CbGeAlD
Orphenadrine—KCNH2—endocardium—dilated cardiomyopathy	0.0106	0.094	CbGeAlD
Orphenadrine—SLC6A2—sympathetic nervous system—dilated cardiomyopathy	0.00466	0.0412	CbGeAlD
Orphenadrine—Gastric irritation—Furosemide—dilated cardiomyopathy	0.00457	0.117	CcSEcCtD
Orphenadrine—Epigastric discomfort—Furosemide—dilated cardiomyopathy	0.00337	0.086	CcSEcCtD
Orphenadrine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00182	0.0465	CcSEcCtD
Orphenadrine—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00166	0.0424	CcSEcCtD
Orphenadrine—SCN5A—cardiac ventricle—dilated cardiomyopathy	0.00145	0.0129	CbGeAlD
Orphenadrine—SCN5A—myocardium—dilated cardiomyopathy	0.00137	0.0121	CbGeAlD
Orphenadrine—Aprindine—SCN5A—dilated cardiomyopathy	0.00134	0.493	CrCbGaD
Orphenadrine—SCN4A—heart—dilated cardiomyopathy	0.00123	0.0109	CbGeAlD
Orphenadrine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00117	0.0299	CcSEcCtD
Orphenadrine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00116	0.0296	CcSEcCtD
Orphenadrine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00103	0.0263	CcSEcCtD
Orphenadrine—Drowsiness—Furosemide—dilated cardiomyopathy	0.000991	0.0253	CcSEcCtD
Orphenadrine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000957	0.0244	CcSEcCtD
Orphenadrine—SCN5A—heart—dilated cardiomyopathy	0.000954	0.00845	CbGeAlD
Orphenadrine—Urticaria—Spironolactone—dilated cardiomyopathy	0.000923	0.0235	CcSEcCtD
Orphenadrine—KCNH2—cardiac ventricle—dilated cardiomyopathy	0.000894	0.00791	CbGeAlD
Orphenadrine—Mepyramine—SLC22A5—dilated cardiomyopathy	0.000856	0.314	CrCbGaD
Orphenadrine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000856	0.0218	CcSEcCtD
Orphenadrine—KCNH2—myocardium—dilated cardiomyopathy	0.000841	0.00744	CbGeAlD
Orphenadrine—Pruritus—Spironolactone—dilated cardiomyopathy	0.000822	0.021	CcSEcCtD
Orphenadrine—SCN5A—cardiac atrium—dilated cardiomyopathy	0.000816	0.00723	CbGeAlD
Orphenadrine—CHRM2—heart—dilated cardiomyopathy	0.000812	0.00719	CbGeAlD
Orphenadrine—Dizziness—Spironolactone—dilated cardiomyopathy	0.000768	0.0196	CcSEcCtD
Orphenadrine—Vomiting—Spironolactone—dilated cardiomyopathy	0.000739	0.0188	CcSEcCtD
Orphenadrine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00073	0.0186	CcSEcCtD
Orphenadrine—Headache—Spironolactone—dilated cardiomyopathy	0.000728	0.0186	CcSEcCtD
Orphenadrine—Agitation—Furosemide—dilated cardiomyopathy	0.000712	0.0182	CcSEcCtD
Orphenadrine—Nausea—Spironolactone—dilated cardiomyopathy	0.00069	0.0176	CcSEcCtD
Orphenadrine—Hallucination—Lisinopril—dilated cardiomyopathy	0.000664	0.0169	CcSEcCtD
Orphenadrine—Confusional state—Furosemide—dilated cardiomyopathy	0.000637	0.0163	CcSEcCtD
Orphenadrine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000632	0.0161	CcSEcCtD
Orphenadrine—Skin disorder—Furosemide—dilated cardiomyopathy	0.000614	0.0157	CcSEcCtD
Orphenadrine—KCNH2—heart—dilated cardiomyopathy	0.000587	0.00519	CbGeAlD
Orphenadrine—Tension—Lisinopril—dilated cardiomyopathy	0.00057	0.0145	CcSEcCtD
Orphenadrine—Somnolence—Furosemide—dilated cardiomyopathy	0.000562	0.0143	CcSEcCtD
Orphenadrine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000548	0.014	CcSEcCtD
Orphenadrine—Tremor—Lisinopril—dilated cardiomyopathy	0.000544	0.0139	CcSEcCtD
Orphenadrine—Constipation—Furosemide—dilated cardiomyopathy	0.00054	0.0138	CcSEcCtD
Orphenadrine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000521	0.0133	CcSEcCtD
Orphenadrine—Palpitations—Lisinopril—dilated cardiomyopathy	0.000513	0.0131	CcSEcCtD
Orphenadrine—Urticaria—Furosemide—dilated cardiomyopathy	0.000502	0.0128	CcSEcCtD
Orphenadrine—KCNH2—cardiac atrium—dilated cardiomyopathy	0.000502	0.00444	CbGeAlD
Orphenadrine—CYP2B6—heart—dilated cardiomyopathy	0.000482	0.00426	CbGeAlD
Orphenadrine—Confusional state—Lisinopril—dilated cardiomyopathy	0.000478	0.0122	CcSEcCtD
Orphenadrine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000474	0.0121	CcSEcCtD
Orphenadrine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000466	0.0119	CcSEcCtD
Orphenadrine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000463	0.0118	CcSEcCtD
Orphenadrine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000461	0.0118	CcSEcCtD
Orphenadrine—Asthenia—Furosemide—dilated cardiomyopathy	0.000453	0.0116	CcSEcCtD
Orphenadrine—Pruritus—Furosemide—dilated cardiomyopathy	0.000447	0.0114	CcSEcCtD
Orphenadrine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000422	0.0108	CcSEcCtD
Orphenadrine—Dizziness—Furosemide—dilated cardiomyopathy	0.000418	0.0107	CcSEcCtD
Orphenadrine—Constipation—Lisinopril—dilated cardiomyopathy	0.000405	0.0103	CcSEcCtD
Orphenadrine—Vomiting—Furosemide—dilated cardiomyopathy	0.000402	0.0103	CcSEcCtD
Orphenadrine—Headache—Furosemide—dilated cardiomyopathy	0.000396	0.0101	CcSEcCtD
Orphenadrine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000391	0.00997	CcSEcCtD
Orphenadrine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000377	0.00961	CcSEcCtD
Orphenadrine—Nausea—Furosemide—dilated cardiomyopathy	0.000375	0.00958	CcSEcCtD
Orphenadrine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000349	0.00891	CcSEcCtD
Orphenadrine—Asthenia—Lisinopril—dilated cardiomyopathy	0.00034	0.00868	CcSEcCtD
Orphenadrine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000335	0.00856	CcSEcCtD
Orphenadrine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000314	0.008	CcSEcCtD
Orphenadrine—Diphenhydramine—SLC22A5—dilated cardiomyopathy	0.000313	0.114	CrCbGaD
Orphenadrine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000301	0.00769	CcSEcCtD
Orphenadrine—Headache—Lisinopril—dilated cardiomyopathy	0.000297	0.00758	CcSEcCtD
Orphenadrine—Nausea—Lisinopril—dilated cardiomyopathy	0.000282	0.00719	CcSEcCtD
Orphenadrine—Phenoxybenzamine—ADRB2—dilated cardiomyopathy	0.000216	0.0793	CrCbGaD
Orphenadrine—SCN4A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000216	0.00215	CbGpPWpGaD
Orphenadrine—SLC6A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000216	0.00215	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000208	0.00207	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000208	0.00207	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000202	0.00201	CbGpPWpGaD
Orphenadrine—SCN5A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000195	0.00194	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000195	0.00194	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—RAC1—dilated cardiomyopathy	0.000192	0.00191	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000192	0.00191	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.000182	0.00181	CbGpPWpGaD
Orphenadrine—HRH1—IL-4 Signaling Pathway—RPS6KB1—dilated cardiomyopathy	0.000179	0.00178	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	0.000175	0.00174	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000175	0.00174	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000174	0.00173	CbGpPWpGaD
Orphenadrine—CYP2E1—Vitamin A and Carotenoid Metabolism—CD36—dilated cardiomyopathy	0.000173	0.00172	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.000172	0.00171	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—PSEN2—dilated cardiomyopathy	0.000171	0.0017	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000168	0.00167	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000168	0.00167	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.000164	0.00163	CbGpPWpGaD
Orphenadrine—GRIN2D—Alzheimers Disease—TNF—dilated cardiomyopathy	0.00016	0.0016	CbGpPWpGaD
Orphenadrine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000155	0.00155	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000154	0.00153	CbGpPWpGaD
Orphenadrine—SLC6A2—Monoamine Transport—TNF—dilated cardiomyopathy	0.000153	0.00152	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00015	0.0015	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000149	0.00148	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000149	0.00148	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000147	0.00146	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000147	0.00146	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000146	0.00145	CbGpPWpGaD
Orphenadrine—SCN9A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000142	0.00142	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000135	0.00135	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.000135	0.00135	CbGpPWpGaD
Orphenadrine—SCN4A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000131	0.0013	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—ITGB1—dilated cardiomyopathy	0.00013	0.0013	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—ITGB1—dilated cardiomyopathy	0.00013	0.0013	CbGpPWpGaD
Orphenadrine—SCN1A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000126	0.00125	CbGpPWpGaD
Orphenadrine—SCN10A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000126	0.00125	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000122	0.00121	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—RAC1—dilated cardiomyopathy	0.000118	0.00118	CbGpPWpGaD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000117	0.00116	CbGpPWpGaD
Orphenadrine—GRIN1—Alzheimers Disease—TNF—dilated cardiomyopathy	0.000115	0.00114	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000113	0.00112	CbGpPWpGaD
Orphenadrine—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000113	0.00112	CbGpPWpGaD
Orphenadrine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000111	0.00111	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00011	0.00109	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00011	0.00109	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.000109	0.00108	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—RAC1—dilated cardiomyopathy	0.000109	0.00108	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—ITGB1—dilated cardiomyopathy	0.000107	0.00106	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000105	0.00104	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—RAC1—dilated cardiomyopathy	0.000105	0.00104	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—RAC1—dilated cardiomyopathy	0.000105	0.00104	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000105	0.00104	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000102	0.00101	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—ITGB1—dilated cardiomyopathy	9.65e-05	0.00096	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—ITGB1—dilated cardiomyopathy	9.31e-05	0.000926	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—ITGB1—dilated cardiomyopathy	9.31e-05	0.000926	CbGpPWpGaD
Orphenadrine—CHRM2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	9.29e-05	0.000924	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—ITGB1—dilated cardiomyopathy	9.17e-05	0.000912	CbGpPWpGaD
Orphenadrine—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	9.12e-05	0.000907	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—CD36—dilated cardiomyopathy	8.96e-05	0.000891	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	8.95e-05	0.000891	CbGpPWpGaD
Orphenadrine—GRIN2D—Neuronal System—RAF1—dilated cardiomyopathy	8.95e-05	0.00089	CbGpPWpGaD
Orphenadrine—SCN5A—L1CAM interactions—EGFR—dilated cardiomyopathy	8.87e-05	0.000882	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—EGFR—dilated cardiomyopathy	8.75e-05	0.00087	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	8.68e-05	0.000863	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	8.68e-05	0.000863	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—RAC1—dilated cardiomyopathy	8.58e-05	0.000853	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—RAC1—dilated cardiomyopathy	8.44e-05	0.00084	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	8.37e-05	0.000832	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—TNF—dilated cardiomyopathy	8.33e-05	0.000829	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—CD36—dilated cardiomyopathy	8.23e-05	0.000819	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	8.19e-05	0.000814	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	8.14e-05	0.00081	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	8.07e-05	0.000803	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	8.05e-05	0.000801	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—CD36—dilated cardiomyopathy	7.94e-05	0.00079	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—CD36—dilated cardiomyopathy	7.94e-05	0.00079	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—RAF1—dilated cardiomyopathy	7.85e-05	0.00078	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	7.76e-05	0.000772	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—RAC1—dilated cardiomyopathy	7.76e-05	0.000772	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—ITGB1—dilated cardiomyopathy	7.61e-05	0.000757	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	7.61e-05	0.000757	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	7.49e-05	0.000745	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—RAC1—dilated cardiomyopathy	7.48e-05	0.000744	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—RAC1—dilated cardiomyopathy	7.48e-05	0.000744	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—RAC1—dilated cardiomyopathy	7.37e-05	0.000733	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	7.37e-05	0.000733	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	7.28e-05	0.000724	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	7.25e-05	0.000721	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—RAF1—dilated cardiomyopathy	7.21e-05	0.000717	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	7.08e-05	0.000704	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	7.01e-05	0.000698	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	7.01e-05	0.000698	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—RAF1—dilated cardiomyopathy	6.95e-05	0.000692	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—RAF1—dilated cardiomyopathy	6.95e-05	0.000692	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	6.9e-05	0.000686	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	6.9e-05	0.000686	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	6.66e-05	0.000663	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—ITGB1—dilated cardiomyopathy	6.54e-05	0.000651	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	6.52e-05	0.000649	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—CD36—dilated cardiomyopathy	6.49e-05	0.000646	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	6.42e-05	0.000638	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—RAF1—dilated cardiomyopathy	6.41e-05	0.000638	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	6.31e-05	0.000628	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	6.29e-05	0.000626	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	6.21e-05	0.000618	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	6.19e-05	0.000616	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—RAC1—dilated cardiomyopathy	6.12e-05	0.000609	CbGpPWpGaD
Orphenadrine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	5.97e-05	0.000594	CbGpPWpGaD
Orphenadrine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	5.88e-05	0.000584	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	5.73e-05	0.00057	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	5.73e-05	0.00057	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—RAF1—dilated cardiomyopathy	5.69e-05	0.000566	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—RAF1—dilated cardiomyopathy	5.6e-05	0.000557	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—CD36—dilated cardiomyopathy	5.58e-05	0.000555	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	5.55e-05	0.000552	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	5.39e-05	0.000536	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—EGFR—dilated cardiomyopathy	5.38e-05	0.000535	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	5.34e-05	0.000531	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	5.34e-05	0.000531	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—RAF1—dilated cardiomyopathy	5.34e-05	0.000531	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	5.31e-05	0.000528	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—RAC1—dilated cardiomyopathy	5.26e-05	0.000523	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	5.25e-05	0.000523	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	5.25e-05	0.000523	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—RAF1—dilated cardiomyopathy	5.14e-05	0.000512	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	5.12e-05	0.00051	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	5.12e-05	0.000509	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	5.03e-05	0.000501	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	4.96e-05	0.000494	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—RAF1—dilated cardiomyopathy	4.96e-05	0.000493	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—RAF1—dilated cardiomyopathy	4.96e-05	0.000493	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—EGFR—dilated cardiomyopathy	4.94e-05	0.000492	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—RAF1—dilated cardiomyopathy	4.89e-05	0.000486	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	4.89e-05	0.000486	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	4.81e-05	0.000478	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—EGFR—dilated cardiomyopathy	4.77e-05	0.000474	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—EGFR—dilated cardiomyopathy	4.77e-05	0.000474	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	4.73e-05	0.000471	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	4.7e-05	0.000467	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	4.69e-05	0.000467	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	4.42e-05	0.00044	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ANKRD1—dilated cardiomyopathy	4.33e-05	0.000431	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	4.16e-05	0.000414	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	4.11e-05	0.000408	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	4.07e-05	0.000405	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—RAF1—dilated cardiomyopathy	4.06e-05	0.000404	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	4.04e-05	0.000402	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—EGFR—dilated cardiomyopathy	3.9e-05	0.000388	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	3.9e-05	0.000388	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—EGFR—dilated cardiomyopathy	3.84e-05	0.000382	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	3.83e-05	0.000381	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	3.79e-05	0.000377	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	3.76e-05	0.000374	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	3.73e-05	0.000371	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	3.68e-05	0.000366	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—TNF—dilated cardiomyopathy	3.66e-05	0.000364	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	3.56e-05	0.000354	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—EGFR—dilated cardiomyopathy	3.53e-05	0.000351	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—RAF1—dilated cardiomyopathy	3.49e-05	0.000347	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—EGFR—dilated cardiomyopathy	3.4e-05	0.000338	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—EGFR—dilated cardiomyopathy	3.4e-05	0.000338	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—TNF—dilated cardiomyopathy	3.36e-05	0.000334	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—EGFR—dilated cardiomyopathy	3.35e-05	0.000333	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—TNF—dilated cardiomyopathy	3.24e-05	0.000322	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—TNF—dilated cardiomyopathy	3.24e-05	0.000322	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	3.22e-05	0.00032	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	3.02e-05	0.0003	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	3.02e-05	0.0003	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	2.97e-05	0.000295	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	2.97e-05	0.000295	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	2.95e-05	0.000294	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—AGT—dilated cardiomyopathy	2.89e-05	0.000287	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	2.84e-05	0.000283	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	2.81e-05	0.000279	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—EGFR—dilated cardiomyopathy	2.78e-05	0.000277	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	2.76e-05	0.000275	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	2.74e-05	0.000273	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	2.74e-05	0.000273	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	2.72e-05	0.00027	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	2.7e-05	0.000268	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	2.7e-05	0.000268	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	2.67e-05	0.000266	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—TNF—dilated cardiomyopathy	2.65e-05	0.000264	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	2.55e-05	0.000253	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	2.51e-05	0.000249	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.47e-05	0.000245	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	2.44e-05	0.000243	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.43e-05	0.000242	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—EGFR—dilated cardiomyopathy	2.39e-05	0.000238	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.32e-05	0.000231	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.28e-05	0.000227	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—TNF—dilated cardiomyopathy	2.28e-05	0.000227	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.22e-05	0.000221	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.2e-05	0.000219	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.17e-05	0.000215	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.11e-05	0.00021	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	2.07e-05	0.000206	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	2.01e-05	0.0002	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2e-05	0.000199	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.97e-05	0.000196	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	1.89e-05	0.000188	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.82e-05	0.000181	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.79e-05	0.000178	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.71e-05	0.00017	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.71e-05	0.00017	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.68e-05	0.000167	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.63e-05	0.000162	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.62e-05	0.000161	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.62e-05	0.000161	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.61e-05	0.00016	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.59e-05	0.000158	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.59e-05	0.000158	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.55e-05	0.000154	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.53e-05	0.000152	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.51e-05	0.00015	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.48e-05	0.000148	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.48e-05	0.000147	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.46e-05	0.000145	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.46e-05	0.000145	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.43e-05	0.000143	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.24e-05	0.000124	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.22e-05	0.000122	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.18e-05	0.000117	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.16e-05	0.000116	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.03e-05	0.000102	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	1.02e-05	0.000102	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.01e-05	0.000101	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.01e-05	0.000101	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	1e-05	9.95e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.99e-06	9.93e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	9.95e-06	9.89e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	9.74e-06	9.69e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	9.17e-06	9.12e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	9.02e-06	8.97e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	8.96e-06	8.91e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	8.77e-06	8.73e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	8.76e-06	8.71e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	8.62e-06	8.57e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.06e-06	7.02e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.94e-06	6.91e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	6.08e-06	6.05e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	5.98e-06	5.95e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	4.64e-06	4.62e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	4.52e-06	4.5e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	4.17e-06	4.15e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	4.1e-06	4.08e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	4.07e-06	4.05e-05	CbGpPWpGaD
